Report highlights successful fight against prostate cancer

Men with prostate cancer are being seen more quickly and receiving better care according to a new report out today.

The report sets out progress made following the publication of the NHS Prostate Cancer programme four years ago. The programme was the first of its kind and aimed to focus attention on the most commonly diagnosed cancer in men in England and the second biggest cancer killer in men.

According to the report over 98% of patients with suspected prostate cancer are now seen by a consultant within two weeks of being urgently referred by their GP – compared to 40% in 1997. And the number of consultant urologists has increased by 40% - there are now 503 consultants compared to 343 in 1997

Prostate cancer is the only cancer with a government spending target for research - the target of £4.2 million was reached in 2003/04.

Speaking at the National Prostate Cancer Conference, Health Minister Lord Warner said: "Making sure patients have access to the latest treatments is key to reducing the suffering caused by this condition - that is why prostate cancer is the only cancer to have a specific target for government spending on research. This will help to ensure that patients get the benefit of pioneering new techniques like high intensity focused ultrasound for which clinical trials are due to begin early next year."

Speaking on behalf of the Prostate Cancer Charter for Action, Dr Chris Parker said that as prostate cancer remains a big killer "it is right we continue to make tackling prostate cancer our priority".

"Although there has been encouraging progress on tackling prostate cancer there is still a lot to do," he added.


Related UK National News Stories
Click here for the latest headlines.

24 May 2005
Trials for prostate cancer drugs announced
Scientists have announced that they are testing new drugs that could be used to treat advanced prostate cancer. Currently, advanced prostate cancer is treated with hormone therapy. However, this only works for a short period of time, after which there are few other options for the patient, apart from palliative care.
25 September 2009
Screening For Prostate Cancer 'Remains Controversial'
There is not enough evidence to support routine prostate cancer screening. Two papers published on bmj.com today conclude that there is insufficient evidence to support population-wide screening for prostate cancer using the prostate specific antigen (PSA) test.
31 October 2005
Call for action on prostate cancer
The leaders of the three main political parties have issued a joint call for greater action to tackle the problem of prostate cancer. Prime Minister Tony Blair, Conservative leader Michael Howard and Liberal Democrat leader Charles Kennedy have all recorded messages of support for the Prostate Cancer Charter for Action.
16 May 2012
New Info Revises Opinion On Cancer Drug
A prostate cancer drug should be given to NHS patients, a health watchdog has said. The National Institute for Health and Clinical Excellence (Nice) revised its recommendations on the drug Abiratone after fresh information from the manufacturer, Janssen. Experts have welcomed the draft guidance.
08 August 2011
Cancer Survivors 'Should Exercise', Charity Claims
More than a million cancer survivors could be putting themselves at risk of long-term health problems because they are not physically active enough, a report by Macmillan Cancer Support has claimed. The charity's report, Move More, said that of the two million cancer survivors in the UK, around 1.